Joey Wagner of BluePrint Supply Chain explains why it's critical to have a reliable quality assurance program and consistent ...

But after gaining more than 20 pounds during undergraduate and graduate school and feeling unhappy with her weight, the ...

Net sales for the quarter amounted to KSEK 485 (KSEK 271) The loss for the quarter amounted ... quarter was that the ...

the SMI is anticipated to continue its advance in the impulsive phase of orange wave 3, reflecting a strong bullish trend in line with higher-degree wave analysis. The wave cancel invalid level at ...

Generated $196.8 million in 3Q 2024 revenues, including $176.6 million in U.S. net product salesGrew SYFOVRE® (pegcetacoplan injection) demand by ...

Drs Pavan Brahmbhatt and Amit Agarwal discuss best practices for managing amyloid-related imaging abnormalities in patients ...

Prescriptions of this GLP-1 class of diabetes and weight-loss medications ... monitor trade-offs between pharmacologic and ...

Chronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody that targets the ...

Weight management medications are transforming the landscape of obesity treatment, with semaglutide emerging as a ...

Officials reported the Berlin brushfire on Lamentation Mountain is contained Monday though they continue to suppress further ...

Real-world data showed mean BMI decrease of 12.8% in adult patients with acquired hypothalamic obesity (N=8) at three months on setmelanotide ...

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the completion of the ...